The UK has approved its first-ever needle-free adrenaline treatment for severe allergic reactions, marking a major development in how anaphylaxis could be managed in emergencies.
Here, Gerry Morrow discusses whether we will ever see AI fully replicate autonomous decision making and what the future role of AI in diagnostic medicine is.
Department of Health and Social Care announces improvements to the Accelerated Access Collaborative (AAC) that will put the most promising medicines, diagnostic tools and digital services through clinical development and regulatory processes faster.
Mynurva has commissioned a survey among more than 2,000 UK adults to uncover how much support is available for people in full-time work who suffer from mental health problems.
Jérôme Galon, Director of Research and Head of the Laboratory of Integrative Cancer Immunology at INSERM, explains Immunoscore®, an in vitro diagnostic test that predicts the risk of relapse in colon cancer patients.
Goran Nenadic, from The University of Manchester and The Alan Turing Institute, argues for using patient information stored in routinely collected healthcare free-text data.
Taking advantage of data and trustworthy collaboration is the way to go when it comes to a life- and disease course approach to health protection and chronic care, argues Prof Dr Freimut Schliess, Director of Science & Innovation at Profil GmbH.
The UK is set to train many more highly skilled engineers in prosthetics and orthotics following the announcement of a new global centre of excellence based at the University of Salford.
The Department of Health in Northern Ireland pledge to replace the bowel cancer screening test in the country with the new, more accurate Faecal Immunochemical Test (FIT) from early 2020.
The Netherlands’ Ministry of Health, Welfare & Sport is responsible for promoting physical and mental wellbeing, social infrastructure and active lifestyles through participation in sport, as this article details.
European Association for Cancer Research’s Chief Executive Officer, Jane Smith, explains why the advancement of cancer research is purely for the public benefit, as well as the importance of collaboration in the field.
Local councils could become a key player in the use of these emerging technologies for the benefit of the public, but how can they make this digital shift part of their long-term forecasting, and ensure that 5G projects are a success?